Physician profile
Tracey A Carpenter
NPI 1083166433
$47,028.02
in general payments reported to CMS, 2019-2025
48 companies · $9,272 in 2025
The $9,272 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,720 · 2022: $8,963 · 2023: $9,043 · 2024: $11K · 2025: $9,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $9,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,720.00 |
| Food and Beverage | $9,625.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38,166.53 | 2021-2025 | |
| Pfizer INC. | $909.81 | 2023-2025 | |
| Allergan, INC. | $905.04 | 2021 | |
| Supernus Pharmaceuticals, INC. | $899.45 | 2021-2024 | Qelbree |
| Boston Scientific Corporation | $517.68 | 2021-2025 | Watchman Access System, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $500.92 | 2021-2025 | |
| Amgen INC. | $430.83 | 2021-2024 | Uplizna, Aimovig |
| Acadia Pharmaceuticals INC | $392.62 | 2021-2025 | Nuplazid |
| Abbott Laboratories | $353.40 | 2022-2025 | Infinity, Proclaim |
| Teva Pharmaceuticals USA, INC. | $329.24 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lundbeck LLC | $298.37 | 2021-2025 | Vyepti |
| Ucb, INC. | $288.28 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Biohaven Pharmaceutical Holding Company LTD. | $243.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $199.31 | 2021-2022 | |
| Lilly USA, LLC | $197.99 | 2022-2025 | Emgality, Kisunla, Amyvid |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.